These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 819939)

  • 1. Central effects of thyrotropin-releasing factor (TRF); interaction with some antipsychotic drugs.
    Mora S; Loizzo A; Longo VG
    Pharmacol Biochem Behav; 1976 Mar; 4(3):279-82. PubMed ID: 819939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II.
    Huidobro-Toro JP; Scotti de Carolis A; Longo VG
    Pharmacol Biochem Behav; 1975; 3(2):235-42. PubMed ID: 238221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is a dopaminergic system involved in thyrotropin releasing hormone induced hyperthermia and in its potentiation by amphetamine?
    Rips R; Desiles M; Puech AJ
    Prog Neuropsychopharmacol; 1979; 3(4):337-44. PubMed ID: 45568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of behavioral events by thyrotropin releasing factor and cyclic AMP.
    Cohn ML; Cohn M; Krzysik BA; Taylor FH
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):129-33. PubMed ID: 189323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma prolactin and GH response after thyrotropin-releasing hormone (TRH), L-DOPA and sulpiride in patients with senile dementia of Alzheimer type].
    Fujita M; Toyoda K; Motomura N; Kuroda K; Shimizu T
    Rinsho Shinkeigaku; 1985 Jul; 25(7):767-75. PubMed ID: 3935351
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine receptor blocking activity of sulpiride in the central nervous system.
    Honda F; Satoh Y; Shimomura K; Satoh H; Noguchi H; Uchida S; Kato R
    Jpn J Pharmacol; 1977 Jun; 27(3):397-411. PubMed ID: 562433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-dopa hypotension in dogs: evidence for mediation through 5-HT release.
    Antonaccio MJ; Robson RD
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):89-102. PubMed ID: 4281293
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the tripeptides TRH, MIF and MAF on the cerebral dopaminergic system.
    Klusha B; Georgiev V; Petkov V; Markovska V
    Acta Physiol Pharmacol Bulg; 1983; 9(2):14-9. PubMed ID: 6140814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers.
    McClelland GR; Cooper SM; Pilgrim AJ
    Br J Clin Pharmacol; 1990 Dec; 30(6):795-803. PubMed ID: 2288826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural effects of central and peripheral injection of various analogues and metabolites of thyrotropin releasing hormone (TRH).
    Heal DJ; Sabbagh A; Youdim MB; Green AR
    Neuropharmacology; 1981 Oct; 20(10):947-57. PubMed ID: 6795523
    [No Abstract]   [Full Text] [Related]  

  • 11. Blockade of D-1 dopamine receptors by SCH 23390 prevents EEG and behavioral activation induced by L-dopa.
    Ongini E; Caporali MG; Longo VG
    Neurosci Lett; 1987 Nov; 82(2):206-10. PubMed ID: 2962017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin releasing hormone: enhancement of dopa activity by a hypothalamic hormone.
    Plotnikoff NP; Prange AJ; Breese GR; Anderson MS; Wilson IC
    Science; 1972 Oct; 178(4059):417-8. PubMed ID: 4627781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin-releasing hormone: physiological concomitants of behavioral excitation.
    Andry DK; Horita A
    Pharmacol Biochem Behav; 1977 Jan; 6(1):55-9. PubMed ID: 403528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head turning induced by unilateral intracaudate thyrotropin-releasing hormone (TRH) injection in the cat.
    Malouin F; Bédard PJ
    Eur J Pharmacol; 1982 Jul; 81(4):559-67. PubMed ID: 6811294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of SCH 23390 on thyrotropin-releasing hormone-induced behaviour in rabbits.
    Popoli P; Caporali MG; Scotti de Carolis A
    Eur J Pharmacol; 1989 Dec; 173(2-3):211-3. PubMed ID: 2576229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of three neuroleptics on the DOPAC level in the caudate nucleus of the rat].
    Gerardy J; Cajgfinger G
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):197-200. PubMed ID: 5072188
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential behavioural effect of quinpirole in neuroleptic-pretreated rats - role of alpha(1)-adrenoceptor.
    Obuchowicz E
    Eur J Pharmacol; 1999 Nov; 384(2-3):101-9. PubMed ID: 10611430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone response to a novel growth hormone-releasing tripeptide in horses: interaction with gonadotropin-releasing hormone, thyrotropin-releasing hormone, and sulpiride.
    Kennedy SR; Thompson DL; Pruett HE; Burns PJ; Deghenghi R
    J Anim Sci; 2002 Mar; 80(3):744-50. PubMed ID: 11890411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of thyrotropin-releasing hormone (TRH) and other drugs on the actions of alcohol.
    Mailman RB; Frye GD; Mueller RA; Breese GR
    Adv Exp Med Biol; 1980; 126():509-22. PubMed ID: 6250330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of the pharmacological properties of sultopride sulpiride and other antipsychotic drugs: influence of sultopride, sulpiride and other antipsychotic drugs on spontaneous locomotor activity and changes in locomotor activity induced by apomorphine and clonidine in mice].
    Horikomi K; Fujita M
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):339-52. PubMed ID: 2880435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.